A phase 3, randomized study of ofatumumab combined with bendamustine in rituximab-refractory iNHL (COMPLEMENT A + B study)
Date
2021
Advisors/Reviewers
Further Contributors
Publisher
Journal Title
Journal ISSN
Volume Title
Publisher
Quotable link
Abstract
Description
Table of contents
Notes
Original publication in
British journal of haematology 193 (2021), 1123 - 1133